CD36 and colorectal carcinoma: Interestingly, according to data analysis from The Human Protein Atlas, the high mRNA expression of CD36 (n = 131) is associated with poor prognosis in CRC with 5-year survival of 53% of patients as compared to 5-year survival of 64% of patients with low CD36 mRNA expression (n = 466) (30).